DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hézode C, Fourati S, Chevaliez S. , et al.
Sofosbuvir-daclatasvir-simeprevir plus ribavirin in direct-acting antiviral-experienced patients with hepatitis C.
Clin Infect Dis 2017;
64 (11) 1615-1618
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.